Abbott India Ltd
ABBOTINDIAAbbott India Ltd
ABBOTINDIAPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
47.97 | 16.07 | 1.47% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.06 | 6.53 | 0.48% |
Forecast & Ratings
Detailed Forecast from 6 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2,665.09 | 2,960.20 | 3,415.49 | 3,791.89 | 4,207.53 | 4,390.92 | 5,015.73 | 5,533.23 | 6,123.53 | 6,187.12 | ||||||||||
Raw Materials | 1,477.16 | 1,813.51 | 2,006.94 | 2,090.78 | 2,254.39 | 2,494.92 | 2,679.49 | 2,908.97 | 3,212.88 | 4,438.41 | ||||||||||
Power & Fuel Cost | 6.98 | 7.74 | 10.26 | 12.61 | 13.73 | 12.74 | 14.98 | 17.15 | 16.63 | |||||||||||
Employee Cost | 341.09 | 345.27 | 393.69 | 435.58 | 476.11 | 492.65 | 579.46 | 563.59 | 576.58 | |||||||||||
Selling & Administrative Expenses | 343.35 | 353.66 | 365.41 | 432.83 | 400.27 | 366.98 | 459.18 | 467.74 | 429.89 | |||||||||||
Operating & Other expenses | 81.54 | -14.93 | -2.30 | 102.07 | 192.19 | 21.27 | 117.69 | 216.00 | 186.18 | |||||||||||
EBITDA | 414.97 | 454.95 | 641.49 | 718.02 | 870.84 | 1,002.36 | 1,164.93 | 1,359.78 | 1,701.37 | 1,748.71 | ||||||||||
Depreciation/Amortization | 14.44 | 16.43 | 16.19 | 16.92 | 59.61 | 58.13 | 66.10 | 69.97 | 71.17 | 72.37 | ||||||||||
PBIT | 400.53 | 438.52 | 625.30 | 701.10 | 811.23 | 944.23 | 1,098.83 | 1,289.81 | 1,630.20 | 1,676.34 | ||||||||||
Interest & Other Items | 2.52 | 2.04 | 3.82 | 2.25 | 8.53 | 18.28 | 19.10 | 15.99 | 12.45 | 11.86 | ||||||||||
PBT | 398.01 | 436.48 | 621.48 | 698.85 | 802.70 | 925.95 | 1,079.73 | 1,273.82 | 1,617.75 | 1,664.48 | ||||||||||
Taxes & Other Items | 142.76 | 159.84 | 220.26 | 248.52 | 209.77 | 235.26 | 281.03 | 324.41 | 416.53 | 425.49 | ||||||||||
Net Income | 255.25 | 276.64 | 401.22 | 450.33 | 592.93 | 690.69 | 798.70 | 949.41 | 1,201.22 | 1,238.99 | ||||||||||
EPS | 120.12 | 130.19 | 188.82 | 211.93 | 279.04 | 325.04 | 375.87 | 446.80 | 565.30 | 583.07 | ||||||||||
DPS | 35.00 | 40.00 | 55.00 | 65.00 | 250.00 | 275.00 | 275.00 | 325.00 | 410.00 | 325.00 | ||||||||||
Payout ratio | 0.29 | 0.31 | 0.29 | 0.31 | 0.90 | 0.85 | 0.73 | 0.73 | 0.73 | 0.56 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Abbott India Ltd | 49.48 | 16.07 | 1.47% |
Sun Pharmaceutical Industries Ltd | 46.25 | 6.60 | 0.73% |
Cipla Ltd | 32.09 | 4.93 | 0.79% |
Torrent Pharmaceuticals Ltd | 68.49 | 16.55 | 0.84% |
Price Comparison
Compare ABBOTINDIA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Abbott India Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
SBI Large & Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.2531% | Percentage of the fund’s portfolio invested in the stock 2.63% | Change in the portfolio weight of the stock over the last 3 months 0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/87 (-38) |
Axis Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8275% | Percentage of the fund’s portfolio invested in the stock 1.58% | Change in the portfolio weight of the stock over the last 3 months 0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/108 (-4) |
Canara Robeco Emerging Equities - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8155% | Percentage of the fund’s portfolio invested in the stock 1.92% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 11/85 (+1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
ABBOTINDIA has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 1.48%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹14.76 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 19, 2024
Dividend/Share
₹410.00
Ex DateEx Date
Jul 19, 2024
Cash Dividend
Ex DateEx DateJul 21, 2023
Dividend/Share
₹145.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 21, 2023
Dividend/Share
₹180.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateAug 2, 2022
Dividend/Share
₹145.00
Ex DateEx Date
Aug 2, 2022
Cash Dividend
Ex DateEx DateAug 2, 2022
Dividend/Share
₹130.00
Ex DateEx Date
Aug 2, 2022
Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against Rs 290.24 crore during the previous quarter ended June 2023. Sales rose 5.32% to Rs 1557.61 crore in the quarter ended June 2024 as against Rs 1479.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1557.611479.00 5 OPM %25.1024.00 - PBDT455.59407.66 12 PBT437.22390.49 12 NP328.01290.24 13 Powered by Capital Market - Live
Abbott India will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Dexcom plunges as revenue forecast cut spooks investors
Pharma Q1 Results Preview - High Value Products Outpacing Price Erosion: Axis Securities
Abbott eyes 45% female representation in management team, 1 lakh youths in STEM programmes by 2030
New buy signal generated in these 4 F&0 scrips as per RMI scanner
Abbott India Q3 Profit Beats Estimates, Propels Shares Over 9% To Record High
Trade setup for Tuesday: 15 things to know before opening bell
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.06%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 1.73% to 1.62%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 21.68%, vs industry avg of 15.28%